Looking to scale up your #cellandgenetherapy #clinicaltrial? We have the therapeutic expertise to elevate your research to new heights. We bring extensive experience in efficiently managing large-scale trials, optimizing processes and ensuring regulatory compliance every step of the way. Our expertise in logistics, data management and patient recruitment streamlines operations, enabling seamless expansion while maintaining quality and safety standards. Learn more about how we can support your cell and gene therapy research. » https://bit.ly/3V8YOOd
PPD
Research Services
Wilmington, NC 584,052 followers
Helping deliver life-changing therapies
About us
PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
- Website
-
https://www.ppd.com
External link for PPD
- Industry
- Research Services
- Company size
- 10,001+ employees
- Headquarters
- Wilmington, NC
- Type
- Public Company
- Specialties
- clinical research, drug development, CRO, patient recruitment, laboratory, pharmaceutical, biotechnology, biopharma, biopharmaceutical, consulting, therapeutics, Functional Service Partnerships, consulting, Early Development, Post-Approval, medical writing, drug information, pharmacovigilance, biostatistics, and bioanalytical
Locations
Employees at PPD
Updates
-
PPD reposted this
“Early on, [focus on] understanding what’s important to patients and their families so that they stay engaged with the trial, what’s important to the sites in terms of how to arrange the day to be less burdensome, and then how to really understand what’s clinically meaningful to the patients and their parents from a protocol perspective.” In the latest episode of ACRO’s Good Clinical Podcast, Susan McCune, MD, VP, Pediatrics & Clinical Pharmacology, PPD and Jacqui Whiteway, Senior Director & Pediatric Strategy Liaison, Center for Pediatric Clinical Development, ICON plc, discuss what makes pediatric clinical trials unique and how industry can make participation easier for pediatric patients and their families. Listen to the full episode: https://lnkd.in/gdMz_agR
-
Seeking to develop #neurodegenerative disorder treatments? Partner with our experienced #clinicalresearch team, equipped with operational and medical expertise across multiple indications, to explore novel approaches like #decentralizedtrials and clinical trial simulations. » https://bit.ly/3xyIXOQ
-
-
"This new building was purpose-built with our specific lab needs in mind, and the work performed here in Middleton will continue to have a major impact on the future of clinical research and development." We recently cut the ribbon on a new facility at our GMP laboratory in Middleton, Wisconsin, an expansion that enhances our analytical capabilities through high quality scientific expertise and industry-leading technologies to help our customers bring safe, effective medicines to patients. 📰 » https://bit.ly/4fnW1IH
-
Working with an end-to-end, integrated CRO and CDMO partner provides sponsors with a wide range of innovative capabilities. Our integrated solutions can help accelerate innovation through integrated timelines, joint project management and streamlined information sharing, expedited communication within the integrated structure, proactive risk mitigation and swift adaptation of strategies, and faster decision-making capabilities through visibility of key project milestones. Learn more about our solutions. » https://bit.ly/3XBmdc8 #drugdevelopment #biopharmaceuticals #clinicalresearch
-
-
We’re looking forward to #AAIC24 and coming together with the global research community to share and discuss the latest progress in understanding, diagnosing, treating and preventing #AlzheimersDisease and related #dementias. Meet our team at booth 920, and join our poster presentation with Stephen J. Peroutka, M.D., Ph.D examining comorbidity profiles of younger vs. older individuals with or without Alzheimer’s. Learn more or pre-book a meeting with us. » https://bit.ly/3y0K3DP
-
There are no U.S. FDA-approved treatments for 95% of rare disorders, creating an immeasurable physical and mental toll on patients and their families. In all of our work, with both adult and pediatric patients, we recognize the person behind the condition — a focal point in our study designs. Find out more about our work in #rarediseases and methods of overcoming obstacles. » https://bit.ly/3Iexkif
-
-
With a vast array of services spanning the entire #drugdevelopment life cycle, we offer site- and patient-centric solutions for innovative #oncology programs. Learn more about these specialized capabilities. » https://bit.ly/3WofqSu
-
-
Join Abhijit Beerala and Sheila Gibson in a webinar hosted by Pharmaceutical Outsourcing on July 30. Learn more about how #clinicaloperations has evolved to overcome study sponsors’ #drugdevelopment challenges and ensure the advancement of new therapeutics and medical devices, and discover how the #FSP outsourcing model contributes to success. Register now! » https://bit.ly/4czwt9j
Webinar: The Evolution of Clinical Operations and the Growth of FSP Partnerships